Amgen Aktie
WKN: 867900 / ISIN: US0311621009
04.10.2025 12:45:00
|
4 Reasons to Buy Amgen Stock Right Now
Major market indexes such as the S&P 500 declined in the first few months of the year, but have since rebounded significantly. In contrast, biotech giant Amgen (NASDAQ: AMGN) started the year strong, but has not maintained that momentum. Over the past six months, Amgen's shares have declined by 9%. The drugmaker is facing some issues, including upcoming patent cliffs.Even so, there remain strong reasons to invest in Amgen and hold on to its shares for the long haul. Let's consider four of them.Amgen lost patent protection for Prolia, a medicine for bone health, earlier this year. In the next few years, it will encounter other patent cliffs, including that of the cancer drug Krypolis and the immunosuppressant Otezla. The loss of exclusivity for these therapies will impact top-line growth, but as every drugmaker knows, the best way to overcome this challenge is to develop newer drugs.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Amgen Inc.mehr Nachrichten
02.10.25 |
Börse New York in Grün: Dow Jones zeigt sich fester (finanzen.at) | |
01.10.25 |
Dow Jones-Handel aktuell: Dow Jones verbucht schlussendlich Zuschläge (finanzen.at) | |
01.10.25 |
Freundlicher Handel: Dow Jones in der Gewinnzone (finanzen.at) | |
01.10.25 |
NYSE-Handel: Dow Jones auf grünem Terrain (finanzen.at) | |
01.10.25 |
Zuversicht in New York: Am Mittag Pluszeichen im NASDAQ 100 (finanzen.at) | |
30.09.25 |
Freundlicher Handel in New York: Börsianer lassen Dow Jones schlussendlich steigen (finanzen.at) | |
30.09.25 |
Starker Wochentag in New York: NASDAQ 100 letztendlich mit Kursplus (finanzen.at) | |
30.09.25 |
Schwache Performance in New York: NASDAQ 100 nachmittags mit Abgaben (finanzen.at) |
Analysen zu Amgen Inc.mehr Analysen
Aktien in diesem Artikel
Amgen Inc. | 254,20 | 0,67% |
|